Fatty Liver Treatment Market Research 2024 - Industry Analysis, Size, Share, Future Trends, Growth Opportunities And Forecast 2033


Posted February 26, 2024 by saitbrc

Global fatty liver treatment market size is expected to reach $30.11 Bn by 2028 at a rate of 6.3%, segmented as by treatment type, anti-rejection drugs or immunosuppressants, chemotherapy drugs, targeted therapy, vaccines, anti-viral drugs
 
The Fatty Liver Treatment Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Fatty Liver Treatment Market:
https://www.thebusinessresearchcompany.com/report/fatty-liver-treatment-global-market-report

According to The Business Research Company’s Fatty Liver Treatment Global Market Report 2024, The fatty liver treatment market size has grown strongly in recent years. It will grow from $22.17 billion in 2023 to $23.58 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to obesity epidemic, sedentary lifestyles, unhealthy diets, limited treatment options, awareness campaigns.

The fatty liver treatment market size is expected to see strong growth in the next few years. It will grow to $30.11 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increased disease prevalence, rising healthcare expenditure, growing diabetes and metabolic syndrome, innovation in therapeutics. Major trends in the forecast period include precision medicine approaches, lifestyle modification programs, targeted therapies for nash, non-invasive monitoring tools, technological advancements.

The increase in alcohol consumption is expected to propel the growth of the fatty liver treatment market going forward. Alcohol consumption refers to consuming beverages containing alcohol, a psychoactive substance with depressant effects on the central nervous system. Alcohol consumption can worsen fatty liver disease and lead to more severe liver conditions, including alcoholic fatty liver disease (AFLD) and alcoholic hepatitis. For instance, in December 2022, according to a report published by Kirin Holdings Company Limited, a Japan-based beverages company, about 185.60 million kiloliters of beer were consumed worldwide in 2021, a rise of 4.0% from 2020. Therefore, the increase in alcohol consumption is driving the growth of the fatty liver treatment market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=12581&type=smp

The fatty liver treatment market covered in this report is segmented –
1) By Treatment Type: Anti-Rejection Drugs Or Immunosuppressants, Chemotherapy Drugs, Targeted Therapy, Vaccines, Anti-Viral Drugs
2) By Disease Type: Hepatitis, Liver Cancer, Non-Alcoholic Fatty Liver Disease, Other Diseases
3) By End User: Hospitals, Ambulatory Surgery Centers, Other End Users

Top Major Players
Pfizer Inc.
Johnson & Johnson Services Inc.
Hoffmann La Roche Ltd.
AstraZeneca PLC
Merck & Co. Inc.

Product innovation is a key trend gaining popularity in the fatty liver treatment market. Major companies operating in fatty liver treatment are developing innovative products to strengthen their position in the market. For instance, in March 2023, Akero Therapeutics, a US-based biotechnology company, reported positive Phase II reports of efruxifermin, indicated for the treatment of non-invasively diagnosed nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). It is a differentiated Fc-FGF21 fusion protein that mimics the biological activity of fibroblast growth factor 21 (FGF21), which regulates multiple metabolic pathways and cellular processes.

The fatty liver treatment market report table of contents includes:
1. Executive Summary
2. Fatty Liver Treatment Market Characteristics
3. Fatty Liver Treatment Market Trends And Strategies
4. Fatty Liver Treatment Market - Macro Economic Scenario
5. Global Fatty Liver Treatment Market Size and Growth
.............................
32. Global Fatty Liver Treatment Market Competitive Benchmarking
33. Global Fatty Liver Treatment Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Fatty Liver Treatment Market
35. Fatty Liver Treatment Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By TBRC
Country United States
Categories Health
Tags fatty liver treatment market , fatty liver treatment market share , fatty liver treatment market size
Last Updated February 26, 2024